Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01243931 · ClinicalTrials.gov registry record · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
A NA study of Corneal Opacity, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT01243931: Recruiting NA study of Corneal Opacity, sponsored by Oregon Health and Science University.
NCT01243931 is a NA study of Corneal Opacity that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01243931, a NA study of Corneal Opacity, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Optical Coherence Tomography (OCT) machines are non-contact instruments that can measure the depth of scars and other causes of cloudiness in the front of the cornea. The purpose of this study is to determine whether OCT-guided settings for the lasers used for removal of corneal scars and other partial-thickness corneal defects result in improved vision in patients receiving these procedures.
Primary Outcome
The primary goal of the trial is to determine the efficacy of the OCT-guided PTK treatment of corneal opacities. During the course of the trial, we will compare the predictive accuracy of the original OCT-guided PTK planning system to the OCT topography-guided system. BSCVA will be measured in typical Snellen acuity notation as 20/xx (feet)
Conditions Studied
Interventions
- DRUG OCT-guided laser phototherapeutic keratectomy
Study Locations (1)
Oregon
- Casey Eye Institute, Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2011-06 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT01243931 shows while recruiting
NCT01243931 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Corneal Opacity appearing as the primary indexed condition, and to 1 intervention - of which OCT-guided laser phototherapeutic keratectomy is the first listed.
NCT01243931 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT01243931 about?
NCT01243931 is a clinical study titled "Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy". Optical Coherence Tomography (OCT) machines are non-contact instruments that can measure the depth of scars and other causes of cloudiness in the front of the cornea. The purpose of this study is to determine whether OCT-guided settings for the lasers used for removal of corneal scars and other part...
What is the current status of trial NCT01243931?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2011-06. Estimated completion is 2026-12.
What conditions does trial NCT01243931 study?
This clinical trial studies the following conditions: Corneal Opacity.
What interventions are being tested in trial NCT01243931?
The interventions under investigation include: OCT-guided laser phototherapeutic keratectomy (DRUG).
Who is sponsoring clinical trial NCT01243931?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01243931 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Corneal Opacity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01243931's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
- NCT02019706 · 80 participants · Phase 2
Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia